Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B.

Author: BalkanIlker Inanc, BayramlarOsman Faruk, KaraaliRidvan, MeteBilgul, OzdemirYusuf Emre, Sahin OzdemirMeryem, SaltogluNese, SurmeSerkan, TabakFehmi, Yildiz KayaSibel

Paper Details 
Original Abstract of the Article :
BACKGROUND/AIMS: We aimed to explore long-term results of oral antiviral agents in treatment-naïve "HBeAg negative chronic hepatitis B (CHB)" and determine the factors affecting the complete virological response. METHOD: Patients with HBeAg-negative CHB who used oral antiviral agents for at least 3...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s11845-022-03066-y

データ提供:米国国立医学図書館(NLM)

Hepatitis B: A Desert of Viral Infections

This research dives into the challenging world of chronic hepatitis B (CHB), a persistent viral infection that can lead to serious liver complications. It's like a vast desert landscape, where the virus persists and can cause significant damage over time. This study investigates the long-term effectiveness of oral antiviral agents in treating HBeAg-negative CHB, which is like finding a way to control the spread of a desert plague. The researchers are like skilled desert doctors, seeking a cure for this viral infection.

Antiviral Agents: A Desert Oasis for the Liver

The study found that all four antiviral agents studied (tenofovir disoproxil fumarate, lamivudine, entecavir, and telbivudine) achieved similar rates of complete virological response (CVR), indicating that they effectively suppressed the virus. It's like finding a series of oases in the desert, each offering a source of relief and a chance to replenish the body's resources. However, the study also highlighted potential side effects and the risk of drug resistance, which are like hidden dangers lurking in the desert.

Navigating the Desert of CHB

This research provides valuable information for treating CHB, highlighting the importance of long-term monitoring and management of the infection. It's like ensuring a steady supply of water and provisions for a long desert journey. By understanding the strengths and limitations of different antiviral agents, healthcare professionals can provide the best possible care for patients with CHB, minimizing the risk of complications and improving their long-term health.

Dr.Camel's Conclusion

This research offers hope for patients with CHB, demonstrating the potential of antiviral agents to control the infection and improve their overall health. It's like discovering a series of oases in the desert, providing a lifeline for those facing the challenges of this viral infection. However, the study also underscores the importance of vigilance and ongoing management, reminding us that the journey through the desert of CHB requires continuous care and attention.

Date :
  1. Date Completed 2023-04-04
  2. Date Revised 2023-04-04
Further Info :

Pubmed ID

35715665

DOI: Digital Object Identifier

10.1007/s11845-022-03066-y

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.